KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KORU Medical Systems 2024年第一季度調整後每股收益美元（0.02）超過預期（0.04），銷售額爲819.8萬美元，超過74.67億美元的預期
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 50 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $8.198 million which beat the analyst consensus estimate of $7.467 million by 9.80 percent. This is a 10.89 percent increase over sales of $7.393 million the same period last year.
KORU Medical Systems（納斯達克股票代碼：KRMD）公佈的季度虧損爲每股0.02美元，比分析師普遍預期的0.04美元（0.04美元）高出50％。這比去年同期每股虧損0.04美元（0.04）增加了50％。該公司公佈的季度銷售額爲819.8萬美元，比分析師普遍預期的746.7萬美元高出9.80％。這比去年同期的739.3萬美元的銷售額增長了10.89％。